Daishin Chemical Co Ltd

Daishin Chemical maintains a strong liquidity position with a current ratio of 2.3, indicating the company can cover its short-term obligations more than twice over. The company's liquidity is further supported by cash and equivalents of ¥7.1 billion, which represents a significant portion of its total assets. The debt-to-equity ratio is effectively zero, suggesting the company is not leveraged and has minimal long-term debt obligations. Profitability metrics show a return on equity (ROE) of 3.56% and a return on assets (ROA) of 2.33%, which are below the typical thresholds for high-performing chemical firms. These returns suggest the company is generating modest returns relative to its equity and asset base. Gross profit of ¥4.3 billion and operating income of ¥757 million indicate a relatively narrow margin structure, which is common in the commodity chemicals industry. The company's revenue is concentrated in Japan, with no disclosed international operations in the provided data. This geographic concentration may expose the company to regional economic fluctuations and regulatory changes. The business is segmented around thinner products, with no additional disclosed segments, suggesting a focused but potentially vulnerable product portfolio. Looking ahead, the company's revenue is expected to remain stable, with no significant growth or decline projected in the next fiscal year. The operating cash flow of ¥2.7 billion and free cash flow of ¥550 million support this stability, indicating the company can fund operations and potentially reinvest in the business. However, capital expenditures are negative, suggesting asset disposals or reduced investment in new projects. Risk factors for Daishin Chemical are currently low, with no immediate liquidity or dilution flags detected. The company's low debt levels and strong cash position reduce financial risk. However, the modest ROE and ROA suggest the company may struggle to outperform industry peers in terms of profitability. The absence of dilution risk is a positive, but the company's reliance on a narrow product line and geographic concentration could pose long-term challenges. Recent filings and transcripts do not indicate any material events or strategic shifts. The company's last actual EPS was 128.55 JPY, and its last actual revenue was ¥34.7 billion, aligning with the disclosed financials. No significant changes in business strategy or capital structure were reported in the latest disclosures.